![Krishnan Nandabalan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Krishnan Nandabalan
Gründer bei BioXcel Corp.
Aktive Positionen von Krishnan Nandabalan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioXcel Corp.
![]() BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | 01.01.2005 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.09.2014 | - | |
Gründer | 01.01.2005 | - | |
Präsident | 01.01.2005 | - | |
Unternehmenssekretär | 01.01.2005 | - | |
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Vorstandsvorsitzender | 01.11.2021 | - |
Vorsitzender | 01.11.2021 | - | |
Präsident | 01.11.2021 | - | |
Autism Impact Fund
![]() Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | Berater | - | - |
Inveniai LLC | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Präsident | - | - |
Karriereverlauf von Krishnan Nandabalan
Ehemalige bekannte Positionen von Krishnan Nandabalan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOXCEL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2017 | 19.09.2023 |
Corporate Officer/Principal | 01.01.2020 | 19.09.2023 | |
AyuGen Biosciences Pvt Ltd.
![]() AyuGen Biosciences Pvt Ltd. Medical/Nursing ServicesHealth Services AyuGen Biosciences Pvt Ltd. is a private organization founded in 2005 that focuses on specialized genomic tests and services. The private company is based in Pune, India. The Indian company's mission is to provide world-class preventive and diagnostic genomic tests to correctly identify the cause of the disease, and subsequently treat it with the correct medicine and right dose to minimize potential side effects. AyuGen aims to bridge the gaps between the current medical practices and the new "personalized" genomic based medical practices for prevention and better treatment. | Direktor/Vorstandsmitglied | 01.03.2006 | 01.10.2015 |
Genaissance Pharmaceuticals, Inc.
![]() Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.1998 | 01.10.2000 |
Corporate Officer/Principal | 01.10.2000 | 01.09.2005 | |
Technology Systems
![]() Technology Systems Computer Processing HardwareElectronic Technology Part of Aryt Industries Ltd., Technology Systems is an American company that develops training simulators. Technology Systems was acquired by Aryt Industries Ltd. on 2000-09-12 for $5.0 million. | Direktor/Vorstandsmitglied | 01.10.2000 | 01.10.2000 |
Ausbildung von Krishnan Nandabalan
Tamilnadu Agricultural University | Graduate Degree |
Indian Institute of Science | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Indien | 4 |
Operativ
Director/Board Member | 5 |
President | 3 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOXCEL THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
BioXcel Corp.
![]() BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Technology Services |
Genaissance Pharmaceuticals, Inc.
![]() Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
AyuGen Biosciences Pvt Ltd.
![]() AyuGen Biosciences Pvt Ltd. Medical/Nursing ServicesHealth Services AyuGen Biosciences Pvt Ltd. is a private organization founded in 2005 that focuses on specialized genomic tests and services. The private company is based in Pune, India. The Indian company's mission is to provide world-class preventive and diagnostic genomic tests to correctly identify the cause of the disease, and subsequently treat it with the correct medicine and right dose to minimize potential side effects. AyuGen aims to bridge the gaps between the current medical practices and the new "personalized" genomic based medical practices for prevention and better treatment. | Health Services |
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
Technology Systems
![]() Technology Systems Computer Processing HardwareElectronic Technology Part of Aryt Industries Ltd., Technology Systems is an American company that develops training simulators. Technology Systems was acquired by Aryt Industries Ltd. on 2000-09-12 for $5.0 million. | Electronic Technology |
Autism Impact Fund
![]() Autism Impact Fund Investment ManagersFinance Autism Impact Fund (AIF) is a venture capital firm founded by Christopher Male and Christopher Male in 2020. the firm is headquartered in Orlando, Florida. | Finance |
Inveniai LLC |
- Börse
- Insiders
- Krishnan Nandabalan
- Erfahrung